| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 989,000 | 1,084,000 | 1,555,000 | 1,692,000 | | Cost of Revenue | 719,000 | 777,000 | 820,000 | 840,000 | | | Gross Profit | 270,000 | 307,000 | 735,000 | 852,000 | | | Operating Expenses | | Research Development | 151,000 | 153,000 | 160,000 | 163,000 | | Selling General and Administrative | 207,000 | 179,000 | 220,000 | 260,000 | | Non Recurring | 169,000 | (6,000) | 4,000 | 9,000 | | Others | 3,000 | 4,000 | 2,000 | 3,000 | | | | Total Operating Expenses | 530,000 | 330,000 | 386,000 | 435,000 | | | | Operating Income or Loss | (260,000) | (23,000) | 349,000 | 417,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27,000 | (22,000) | (8,000) | 61,000 | | Earnings Before Interest And Taxes | (38,000) | (45,000) | 341,000 | 478,000 | | Interest Expense | 14,000 | 11,000 | 15,000 | 15,000 | | Income Before Tax | (52,000) | (56,000) | 326,000 | 463,000 | | Income Tax Expense | (66,000) | (23,000) | (60,000) | (2,388,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,000 | 249,000 | 768,000 | 3,211,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,000 | 249,000 | 768,000 | 3,211,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,000 | $249,000 | $768,000 | $3,211,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
